作者: Brian Mckittrick , Andrew W. Stamford , Zhaoning Zhu , Ying Huang , Elizabeth M. Smith
DOI:
关键词:
摘要: Disclosed are compounds of the formula (I) Chemical should be inserted here as it appears on abstract in paper form or a stereoisomer, tautomer, pharmaceutically acceptable salt solvate thereof, wherein U, W, R, R1, R2, R3 and R4 defined specification; pharmaceutical compositions comprising (I). Also disclosed is method inhibiting aspartyl protease, particular, methods treating cardiovascular diseases, cognitive neurodegenerative diseases. diseases using combination with cholinesterase inhibitor muscarinic m1 agonist m2 antagonist.